Chemical
Browse
Active Pharmaceutical Ingredients
Bioactive chemicals
Agrochemicals
Search
Chemical Structure
Explore
Chemical Similarity
Transformation
Browse
Prodrugs
Drug Metabolites
Metabolite Datasets
Cytochrome P450
Homo sapiens »
CYP1
CYP2
CYP3
CYP4
CYP5
CYP7
CYP8
CYP11
CYP17
CYP19
CYP20
CYP21
CYP24
CYP26
CYP27
CYP39
CYP46
CYP51
Mus musculus
Danio rerio
Oncorhynchus mykiss
Comparison of CYPs
Biochemical Action
Browse
Target Level (ChEMBL)
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Mechanism of action
Search
Mechanism of action
BLAST against human drug target
BLAST against selected species (UniProt)
Exposure
Browse
Monitoring data
Downloads
Web services
Bulk downloads
About
About EcoDrug+
Citing
Data Sources
FAQ
Contact Us
Versions
Display Options:
Molecule Type
Mechanism of Action
Route of Adminstration
Status
Therapeutic Indication
Number of compounds:
7959
MANGAFODIPIR
(1997)
Small molecule
Diagnostic
Unknown
Approved
Unknown
MANGAFODIPIR
×
Maximum Phase:
4
First Approval:
1997
UNII:
N02W67RKJS
Molecule Type:
Small molecule
Molecular Formula:
C22H30MnN4O14P2
Molecular Weight:
691.38
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
ALATROFLOXACIN MESYLATE
(1997)
Small molecule
Bacterial DNA gyrase inhibitor
INJECTION
Approved
Unknown
ALATROFLOXACIN MESYLATE
×
Maximum Phase:
4
First Approval:
1997
UNII:
2IXX802851
Molecule Type:
Small molecule
Molecular Formula:
C27H29F3N6O8S
Molecular Weight:
654.62
AlogP:
0.9
PSA:
159.65
HBD:
4.0
HBA:
#RotB:
7.0
Source:
RALOXIFENE HYDROCHLORIDE
(1997)
Small molecule
Estrogen receptor beta modulator
ORAL
Approved
Breast Neoplasms; Osteoporosis
RALOXIFENE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1997
UNII:
4F86W47BR6
Molecule Type:
Small molecule
Molecular Formula:
C28H28ClNO4S
Molecular Weight:
510.06
AlogP:
6.08
PSA:
70.0
HBD:
2.0
HBA:
#RotB:
7.0
Source:
ARBUTAMINE
(1997)
Small molecule
Unknown
Unknown
Approved
Cardiovascular Diseases
ARBUTAMINE
×
Maximum Phase:
4
First Approval:
1997
UNII:
B07L15YAEV
Molecule Type:
Small molecule
Molecular Formula:
C18H23NO4
Molecular Weight:
317.39
AlogP:
2.45
PSA:
92.95
HBD:
5.0
HBA:
#RotB:
8.0
Source:
MIBEFRADIL DIHYDROCHLORIDE
(1997)
Small molecule
Voltage-gated T-type calcium channel blocker
Unknown
Approved
Unknown
MIBEFRADIL DIHYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1997
UNII:
842TUP3PQ8
Molecule Type:
Small molecule
Molecular Formula:
C29H40Cl2FN3O3
Molecular Weight:
568.56
AlogP:
5.27
PSA:
67.45
HBD:
1.0
HBA:
#RotB:
11.0
Source:
SIBUTRAMINE HYDROCHLORIDE
(1997)
Small molecule
Monoamine transporter inhibitor
ORAL
Approved
Unknown
SIBUTRAMINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1997
UNII:
OGM0YHD1WF
Molecule Type:
Small molecule
Molecular Formula:
C17H29Cl2NO
Molecular Weight:
334.33
AlogP:
4.74
PSA:
3.24
HBD:
0.0
HBA:
#RotB:
5.0
Source:
EPROSARTAN
(1997)
Small molecule
Unknown
Unknown
Approved
Cardiovascular Diseases
EPROSARTAN
×
Maximum Phase:
4
First Approval:
1997
UNII:
2KH13Z0S0Y
Molecule Type:
Small molecule
Molecular Formula:
C23H24N2O4S
Molecular Weight:
424.52
AlogP:
4.74
PSA:
92.42
HBD:
2.0
HBA:
#RotB:
10.0
Source:
CLOPIDOGREL BISULFATE
(1997)
Small molecule
Purinergic receptor P2Y12 antagonist
ORAL
Approved
Acute Coronary Syndrome; Angina, Unstable; Ischemia; Myocardial Infarction; Peripheral Arterial Disease; Stroke
CLOPIDOGREL BISULFATE
×
Maximum Phase:
4
First Approval:
1997
UNII:
08I79HTP27
Molecule Type:
Small molecule
Molecular Formula:
C16H18ClNO6S2
Molecular Weight:
419.91
AlogP:
3.67
PSA:
29.54
HBD:
0.0
HBA:
#RotB:
3.0
Source:
IRBESARTAN
(1997)
Small molecule
Type-1 angiotensin II receptor antagonist
Unknown
Approved
Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Hypertension; Kidney Failure, Chronic
IRBESARTAN
×
Maximum Phase:
4
First Approval:
1997
UNII:
J0E2756Z7N
Molecule Type:
Small molecule
Molecular Formula:
C25H28N6O
Molecular Weight:
428.54
AlogP:
4.78
PSA:
87.13
HBD:
1.0
HBA:
#RotB:
7.0
Source:
DELAVIRDINE MESYLATE
(1997)
Small molecule
Human immunodeficiency virus type 1 reverse transcriptase inhibitor
Unknown
Approved
Unknown
DELAVIRDINE MESYLATE
×
Maximum Phase:
4
First Approval:
1997
UNII:
421105KRQE
Molecule Type:
Small molecule
Molecular Formula:
C23H32N6O6S2
Molecular Weight:
552.68
AlogP:
2.72
PSA:
110.43
HBD:
3.0
HBA:
#RotB:
6.0
Source:
ARBUTAMINE HYDROCHLORIDE
(1997)
Small molecule
Unknown
INJECTION
Approved
Unknown
ARBUTAMINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1997
UNII:
K0NF2CPJ7F
Molecule Type:
Small molecule
Molecular Formula:
C18H24ClNO4
Molecular Weight:
353.85
AlogP:
2.45
PSA:
92.95
HBD:
5.0
HBA:
#RotB:
8.0
Source:
DELAVIRDINE
(1997)
Small molecule
Unknown
Unknown
Approved
Virus Diseases
DELAVIRDINE
×
Maximum Phase:
4
First Approval:
1997
UNII:
DOL5F9JD3E
Molecule Type:
Small molecule
Molecular Formula:
C22H28N6O3S
Molecular Weight:
456.57
AlogP:
2.72
PSA:
110.43
HBD:
3.0
HBA:
#RotB:
6.0
Source:
ZOLMITRIPTAN
(1997)
Small molecule
Serotonin 1b (5-HT1b) receptor agonist
NASAL; ORAL
Approved
Migraine Disorders
ZOLMITRIPTAN
×
Maximum Phase:
4
First Approval:
1997
UNII:
2FS66TH3YW
Molecule Type:
Small molecule
Molecular Formula:
C16H21N3O2
Molecular Weight:
287.36
AlogP:
1.92
PSA:
57.36
HBD:
2.0
HBA:
#RotB:
5.0
Source:
LETROZOLE
(1997)
Small molecule
Cytochrome P450 19A1 inhibitor
ORAL
Approved
Breast Neoplasms; Neoplasms
LETROZOLE
×
Maximum Phase:
4
First Approval:
1997
UNII:
7LKK855W8I
Molecule Type:
Small molecule
Molecular Formula:
C17H11N5
Molecular Weight:
285.31
AlogP:
2.66
PSA:
78.29
HBD:
0.0
HBA:
#RotB:
3.0
Source:
NELFINAVIR
(1997)
Small molecule
Unknown
Unknown
Approved
Virus Diseases
NELFINAVIR
×
Maximum Phase:
4
First Approval:
1997
UNII:
HO3OGH5D7I
Molecule Type:
Small molecule
Molecular Formula:
C32H45N3O4S
Molecular Weight:
567.8
AlogP:
4.75
PSA:
101.9
HBD:
4.0
HBA:
#RotB:
9.0
Source:
REPAGLINIDE
(1997)
Small molecule
Sulfonylurea receptor 1, Kir6.2 blocker
ORAL
Approved
Diabetes Mellitus; Diabetes Mellitus, Type 2
REPAGLINIDE
×
Maximum Phase:
4
First Approval:
1997
UNII:
668Z8C33LU
Molecule Type:
Small molecule
Molecular Formula:
C27H36N2O4
Molecular Weight:
452.6
AlogP:
5.22
PSA:
78.87
HBD:
2.0
HBA:
#RotB:
10.0
Source:
TIAGABINE HYDROCHLORIDE
(1997)
Small molecule
GABA transporter 1 inhibitor
ORAL
Approved
Seizures
TIAGABINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1997
UNII:
DQH6T6D8OY
Molecule Type:
Small molecule
Molecular Formula:
C20H26ClNO2S2
Molecular Weight:
412.02
AlogP:
5.04
PSA:
40.54
HBD:
1.0
HBA:
#RotB:
6.0
Source:
TAMSULOSIN HYDROCHLORIDE
(1997)
Small molecule
Adrenergic receptor alpha-1 antagonist
ORAL
Approved
Prostatic Hyperplasia; Prostatic Neoplasms
TAMSULOSIN HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1997
UNII:
11SV1951MR
Molecule Type:
Small molecule
Molecular Formula:
C20H29ClN2O5S
Molecular Weight:
444.98
AlogP:
2.34
PSA:
99.88
HBD:
2.0
HBA:
#RotB:
11.0
Source:
QUETIAPINE FUMARATE
(1997)
Small molecule
Dopamine D2 receptor antagonist
ORAL
Approved
Bipolar Disorder; Depressive Disorder, Major; Schizophrenia
QUETIAPINE FUMARATE
×
Maximum Phase:
4
First Approval:
1997
UNII:
2S3PL1B6UJ
Molecule Type:
Small molecule
Molecular Formula:
C46H54N6O8S2
Molecular Weight:
883.11
AlogP:
2.86
PSA:
48.3
HBD:
1.0
HBA:
#RotB:
5.0
Source:
TILUDRONATE DISODIUM
(1997)
Small molecule
ATP inhibitor
ORAL
Approved
Unknown
TILUDRONATE DISODIUM
×
Maximum Phase:
4
First Approval:
1997
UNII:
BH6M93CIA0
Molecule Type:
Small molecule
Molecular Formula:
C7H7ClNa2O6P2S
Molecular Weight:
362.58
AlogP:
2.07
PSA:
115.06
HBD:
4.0
HBA:
#RotB:
4.0
Source:
TILUDRONIC ACID
(1997)
Small molecule
Unknown
Unknown
Approved
Bone Diseases
TILUDRONIC ACID
×
Maximum Phase:
4
First Approval:
1997
UNII:
6PNS59HP4Y
Molecule Type:
Small molecule
Molecular Formula:
C7H9ClO6P2S
Molecular Weight:
318.61
AlogP:
2.07
PSA:
115.06
HBD:
4.0
HBA:
#RotB:
4.0
Source:
GREPAFLOXACIN
(1997)
Small molecule
Unknown
Unknown
Approved
Bacterial Infections
GREPAFLOXACIN
×
Maximum Phase:
4
First Approval:
1997
UNII:
L1M1U2HC31
Molecule Type:
Small molecule
Molecular Formula:
C19H22FN3O3
Molecular Weight:
359.4
AlogP:
2.28
PSA:
74.57
HBD:
2.0
HBA:
#RotB:
3.0
Source:
GREPAFLOXACIN HYDROCHLORIDE
(1997)
Small molecule
DNA gyrase inhibitor
ORAL
Approved
Unknown
GREPAFLOXACIN HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1997
UNII:
A4ER1Z8N9N
Molecule Type:
Small molecule
Molecular Formula:
C19H23ClFN3O3
Molecular Weight:
395.86
AlogP:
2.28
PSA:
74.57
HBD:
2.0
HBA:
#RotB:
3.0
Source:
CEFDINIR
(1997)
Small molecule
Bacterial penicillin-binding protein inhibitor
ORAL
Approved
Bacterial Infections; Bronchitis, Chronic; Infections; Otitis Media; Pharyngitis; Pneumonia; Tonsillitis
CEFDINIR
×
Maximum Phase:
4
First Approval:
1997
UNII:
CI0FAO63WC
Molecule Type:
Small molecule
Molecular Formula:
C14H13N5O5S2
Molecular Weight:
395.42
AlogP:
-0.17
PSA:
158.21
HBD:
4.0
HBA:
#RotB:
5.0
Source:
UREA C 14
(1997)
Small molecule
Diagnostic agent
Unknown
Approved
Infections
UREA C 14
×
Maximum Phase:
4
First Approval:
1997
UNII:
WBZ6M63TEE
Molecule Type:
Small molecule
Molecular Formula:
CH4N2O
Molecular Weight:
62.05
AlogP:
-0.98
PSA:
69.11
HBD:
2.0
HBA:
#RotB:
0.0
Source:
EMEDASTINE
(1997)
Small molecule
Unknown
Unknown
Approved
Eye Manifestations
EMEDASTINE
×
Maximum Phase:
4
First Approval:
1997
UNII:
9J1H7Y9OJV
Molecule Type:
Small molecule
Molecular Formula:
C17H26N4O
Molecular Weight:
302.42
AlogP:
2.21
PSA:
33.53
HBD:
0.0
HBA:
#RotB:
5.0
Source:
TOREMIFENE CITRATE
(1997)
Small molecule
Estrogen receptor modulator
ORAL
Approved
Breast Neoplasms
TOREMIFENE CITRATE
×
Maximum Phase:
4
First Approval:
1997
UNII:
2498Y783QT
Molecule Type:
Small molecule
Molecular Formula:
C32H36ClNO8
Molecular Weight:
598.09
AlogP:
6.22
PSA:
12.47
HBD:
0.0
HBA:
#RotB:
9.0
Source:
BROMFENAC
(1997)
Small molecule
Unknown
Unknown
Approved
Eye Diseases
BROMFENAC
×
Maximum Phase:
4
First Approval:
1997
UNII:
864P0921DW
Molecule Type:
Small molecule
Molecular Formula:
C15H12BrNO3
Molecular Weight:
334.17
AlogP:
2.89
PSA:
80.39
HBD:
2.0
HBA:
#RotB:
4.0
Source:
DOLASETRON MESYLATE
(1997)
Small molecule
Serotonin 3a (5-HT3a) receptor antagonist
INJECTION; ORAL
Approved
Neoplasms; Postoperative Nausea and Vomiting
DOLASETRON MESYLATE
×
Maximum Phase:
4
First Approval:
1997
UNII:
U3C8E5BWKR
Molecule Type:
Small molecule
Molecular Formula:
C20H26N2O7S
Molecular Weight:
438.5
AlogP:
2.52
PSA:
62.4
HBD:
1.0
HBA:
#RotB:
2.0
Source:
FEPRAZONE
(1997)
Small molecule
Unknown
Unknown
Approved
Arthralgia; Myalgia; Rheumatic Diseases
FEPRAZONE
×
Maximum Phase:
4
First Approval:
1997
UNII:
7BVX6J0CGR
Molecule Type:
Small molecule
Molecular Formula:
C20H20N2O2
Molecular Weight:
320.39
AlogP:
3.95
PSA:
40.62
HBD:
0.0
HBA:
#RotB:
4.0
Source:
PRAMIPEXOLE DIHYDROCHLORIDE
(1997)
Small molecule
D2-like dopamine receptor agonist
ORAL
Approved
Parkinson Disease; Restless Legs Syndrome
PRAMIPEXOLE DIHYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1997
UNII:
3D867NP06J
Molecule Type:
Small molecule
Molecular Formula:
C10H21Cl2N3OS
Molecular Weight:
302.27
AlogP:
1.58
PSA:
50.94
HBD:
2.0
HBA:
#RotB:
3.0
Source:
DOLASETRON
(1997)
Small molecule
Unknown
Unknown
Approved
Nausea
DOLASETRON
×
Maximum Phase:
4
First Approval:
1997
UNII:
82WI2L7Q6E
Molecule Type:
Small molecule
Molecular Formula:
C19H20N2O3
Molecular Weight:
324.38
AlogP:
2.52
PSA:
62.4
HBD:
1.0
HBA:
#RotB:
2.0
Source:
ANAGRELIDE
(1997)
Small molecule
Unknown
Unknown
Approved
Neoplasms
ANAGRELIDE
×
Maximum Phase:
4
First Approval:
1997
UNII:
K9X45X0051
Molecule Type:
Small molecule
Molecular Formula:
C10H7Cl2N3O
Molecular Weight:
256.09
AlogP:
1.93
PSA:
44.7
HBD:
1.0
HBA:
#RotB:
0.0
Source:
EPROSARTAN MESYLATE
(1997)
Small molecule
Type-1 angiotensin II receptor antagonist
ORAL
Approved
Hypertension
EPROSARTAN MESYLATE
×
Maximum Phase:
4
First Approval:
1997
UNII:
8N2L1NX8S3
Molecule Type:
Small molecule
Molecular Formula:
C24H28N2O7S2
Molecular Weight:
520.63
AlogP:
4.74
PSA:
92.42
HBD:
2.0
HBA:
#RotB:
10.0
Source:
QUETIAPINE
(1997)
Small molecule
Unknown
Unknown
Approved
Psychotic Disorders
QUETIAPINE
×
Maximum Phase:
4
First Approval:
1997
UNII:
BGL0JSY5SI
Molecule Type:
Small molecule
Molecular Formula:
C21H25N3O2S
Molecular Weight:
383.52
AlogP:
2.86
PSA:
48.3
HBD:
1.0
HBA:
#RotB:
5.0
Source:
TAMSULOSIN
(1997)
Small molecule
Unknown
Unknown
Approved
Prostatic Hyperplasia
TAMSULOSIN
×
Maximum Phase:
4
First Approval:
1997
UNII:
G3P28OML5I
Molecule Type:
Small molecule
Molecular Formula:
C20H28N2O5S
Molecular Weight:
408.52
AlogP:
2.34
PSA:
99.88
HBD:
2.0
HBA:
#RotB:
11.0
Source:
1
2
…
46
47
48
49
50
51
52
…
221
222
Next »
Download Option
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA